BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 7:21:20 AM | Browse: 57 | Download: 200
 |
Received |
|
2024-07-07 17:00 |
|
Peer-Review Started |
|
2024-07-07 17:00 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-05 20:30 |
|
Revised |
|
2024-09-18 11:26 |
|
Second Decision |
|
2024-10-22 02:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-22 13:46 |
|
Articles in Press |
|
2024-10-22 13:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-24 07:26 |
|
Publish the Manuscript Online |
|
2024-10-31 07:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dong-Hua Liu, Xiao-Ming Dong and Wen-Jie Long |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine |
2022ZYYJ01 |
| Guangzhou Municipal Science and Technology Bureau's 2024 Basic and Applied Basic Research Topic |
2024A04J4254 |
|
| Corresponding Author |
Wen-Jie Long, MD, PhD, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 12 Jichang Road, Guangzhou 510405, Guangdong Province, China. lwj5699@gzucm.edu.cn |
| Key Words |
Heart failure; Type 2 diabetes mellitus; Dapagliflozin; Sacubitril; Cardiovascular outcomes |
| Core Tip |
This study highlights the combined use of dapagliflozin and sacubitril in patients with post-acute myocardial infarction heart failure and type 2 diabetes. The observed improvements in myocardial microcirculation, cardiac function, and glycemic control were significant, alongside a reduced incidence of major adverse cardiovascular events. The findings underscore the potential synergistic benefits of this therapeutic combination; however, long-term outcomes require further investigation. The results support the need for personalized treatment strategies to enhance cardiovascular care in this high-risk patient group. |
| Publish Date |
2024-10-31 07:21 |
| Citation |
<p>Liu DH, Dong XM, Long WJ. Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus. <i>World J Clin Cases</i> 2024; 12(36): 6935-6938</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i36/6935.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i36.6935 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
